1. business volume, we have a very good future, the United States completed 400,000 cases of cardiac surgery each year, we only completed just over 100,000 cases, but our population is several times the others. We completed the number of cardiac surgery hand is small, definitely not our low incidence of pre-cardiac disease, nor is our valve patients less, coronary heart disease, although the proportion of the past is small, but the future is certainly a lot of. The slow number of hands is mainly due to economic constraints and serious imbalance in the distribution of medical levels. Wuhan Union Hospital cardiac surgery Sun Zongquan 2. one of the directions of the development of precordial disease should be to try to correct early, do small children, age do small, those who can not grow up children have a chance to survive. 3. the development of valve disease, in simple valve technology is very mature, and now some new valves, biological valves will gradually appear in front of the mainland cardiac surgeons, bringing more benefits to patients. In addition the improved level of valve forming technology can also bring benefits to some patients and avoid anticoagulation related complications.4. The incidence of coronary artery disease should continue to increase gradually and the prevalence of bypass will become more and more that high. As for the use of on-pump or off-pump or robotics in CABG surgery, we think it is not necessary to be so interested, as long as the blood vessels can be open to solve the problem, that is the fundamental. It also has to do with the background of each surgeon’s initial training, and I don’t think it is necessary to argue about which is better or worse, or what (e.g., off-pump) is the standard for bypass surgery.5. In surgical treatment of end-stage heart disease, we are lagging behind Taiwan and Hong Kong, as well as Singapore. There are many factors in this, both economic and others (such as laws and regulations, ethics, etc.). But this is the path that cardiac surgery will inevitably take. The widespread clinical application of life support systems is a direction. in the early days of IABP, some medical staff would say that it was going to be over when it was on, but now I am afraid that most people would consider it a life-saving thing then; the clinical application of ECMO, in the next few years, will make significant progress. Drugs – IABP – ECMO – artificial heart – heart transplantation, this issue is worth working on in all aspects. In the stage of extensive accumulation of experience in China, we expect to encounter different embarrassments, but this will certainly be one of the directions of cardiac surgery.6. Treatment of large aneurysms, interventional treatment will continue to develop, and arch surgery will continue to mature along with the development of myocardial protection, brain protection, spinal cord and organ protection techniques, and of course, arterial surgery in other parts of the body. In this area, there are not many ideas, we listen to the experience and ideas of other combatants.7. The surgical treatment of atrial fibrillation will also be one of the important directions of cardiac surgery. This is not much delayed in surgery, and if it can be reversed, the benefits are enormous, and hopefully more cardiac surgeons will be interested in it. (Excerpted from Clove 2008)